Observational studyTrials2015

The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.

Peter Bramlage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.